Incorporation of cisplatin into the metal–organic frameworks UiO66-NH2 and UiO66 – encapsulation vs. conjugation
This work demonstrates synthetic strategies for the incorporation of an anticancer drug, cisplatin, and a Pt(iv) cisplatin prodrug into two zirconium-based metal–organic-frameworks (MOFs): UiO66 and UiO66-NH2.
